▶ 調査レポート

インスリングラルギンの世界市場2018

• 英文タイトル:Global Insulin Glargine Sales Market Report 2018
• レポートコード:D101268
• 出版社/出版日:QYResearch / 2018年10月
• レポート形態:英文、PDF、108ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:製薬・医療
• 販売価格(消費税別)
  Single User License¥428,000 (USD4,000)▷ お問い合わせ
  Enterprise License¥856,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、インスリングラルギンの世界市場について調査・分析し、インスリングラルギンのメーカー別販売量、市場シェア分析、種類別販売分析(単回投与バイアル、充填済シリンジ)、用途別販売分析(糖尿病1型治療、糖尿病2型治療)、地域別販売分析(米国、中国、欧州、日本、東南アジア、インド)、価格動向、企業動向、インスリングラルギン産業チェーン分析、世界市場規模予測などを含め、以下の構成でお届けいたします。

・インスリングラルギン市場概要
・インスリングラルギンのメーカー別販売量・メーカー別シェア
・インスリングラルギンの世界市場:種類別販売量(単回投与バイアル、充填済シリンジ)
・インスリングラルギンの世界市場:用途別販売量(糖尿病1型治療、糖尿病2型治療)
・インスリングラルギンの世界市場:地域別販売量・市場シェア
・インスリングラルギンの米国市場規模
・インスリングラルギンの中国市場規模
・インスリングラルギンの欧州市場規模
・インスリングラルギンの日本市場規模
・インスリングラルギンの東南アジア市場規模
・インスリングラルギンのインド市場規模
・インスリングラルギンのメーカー別分析(企業概要、事業概要、製品概要、収益、価格等)
・インスリングラルギンのコスト分析・価格動向
・インスリングラルギンの産業チェーン(サプライチェーン分析)
・インスリングラルギンのマーケティング戦略・販売チャネル、流通業者
・インスリングラルギン市場への影響要因分析
・インスリングラルギンの世界市場予測
・インスリングラルギンの米国市場予測
・インスリングラルギンの中国市場予測
・インスリングラルギンの欧州市場予測
・インスリングラルギンの日本市場予測
・インスリングラルギンの東南アジア市場予測
・インスリングラルギンのインド市場予測
・インスリングラルギンの種類別世界市場予測(単回投与バイアル、充填済シリンジ)
・インスリングラルギンの用途別世界市場予測(糖尿病1型治療、糖尿病2型治療)
...

This report studies the global Insulin Glargine market status and forecast, categorizes the global Insulin Glargine market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).
Insulin glargine, marketed under the names Lantus among others, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 hours, with a “peakless” profile (according to the insulin glargine package insert).
Insulin glargine is a long-acting, man-made version of human insulin. Insulin glargine works by replacing the insulin that is normally produced by the body and by helping move sugar from the blood into other body tissues where it is Used for energy. It also stops the liver from producing more sugar.

There are two type of Insulin glargine, which are Single Dose Vial and Pre-filled Syringe in the market. Considering its function, Insulin glargine is Used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also Used to treat people with type 2 diabetes (condition in which the body does not Used insulin normally and, therefore, cannot control the amount of sugar in the blood) who need insulin to control their diabetes.

We can see that there are just a few companies produce Insulin glargine, the production of them almost approach to 70% of whole market. They have seted plant in Japan, China, German, India, North Americato produce Insulin glargine, and China is the largest plant for Insulin glargine in the world and also the largest consumption country. As the amount of diabetes of increasing of China, the Chinese market will be bigger than North America.

The Industry is affected by the economic development level and policy, so it’s important to put an eye to economic indexes and leaders’ prefer. With the global economic recovery, more and more people pay attention to care about personal health, especially in underdevelopment regions that have a large population and fast economic growth, the need of Insulin glargine will increase.

The global Insulin Glargine market is valued at 5690 million US$ in 2017 and will reach 7780 million US$ by the end of 2025, growing at a CAGR of 4.0% during 2018-2025.

The major players covered in this report
Sanofi-Aventis
Ganlee
Biocon

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
United States
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Single Dose Vial
Pre-filled Syringe
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Treat type2 diabetes
Treat type1 diabetes

The study objectives of this report are:
To analyze and study the global Insulin Glargine sales, value, status (2013-2017) and forecast (2018-2025);
To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
Focuses on the key Insulin Glargine players, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Insulin Glargine are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Insulin Glargine Manufacturers
Insulin Glargine Distributors/Traders/Wholesalers
Insulin Glargine Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company’s specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Insulin Glargine market, by end-use.
Detailed analysis and profiles of additional market players.

レポート目次

Table of Contents

Global Insulin Glargine Sales Market Report 2018
1 Insulin Glargine Market Overview
1.1 Product Overview and Scope of Insulin Glargine
1.2 Classification of Insulin Glargine by Product Category
1.2.1 Global Insulin Glargine Market Size (Sales) Comparison by Type (2013-2025)
1.2.2 Global Insulin Glargine Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3 Single Dose Vial
1.2.4 Pre-filled Syringe
1.3 Global Insulin Glargine Market by Application/End Users
1.3.1 Global Insulin Glargine Sales (Volume) and Market Share Comparison by Application (2013-2025)
1.3.1 Treat type2 diabetes
1.3.2 Treat type1 diabetes
1.4 Global Insulin Glargine Market by Region
1.4.1 Global Insulin Glargine Market Size (Value) Comparison by Region (2013-2025)
1.4.2 United States Insulin Glargine Status and Prospect (2013-2025)
1.4.3 Europe Insulin Glargine Status and Prospect (2013-2025)
1.4.4 China Insulin Glargine Status and Prospect (2013-2025)
1.4.5 Japan Insulin Glargine Status and Prospect (2013-2025)
1.4.6 Southeast Asia Insulin Glargine Status and Prospect (2013-2025)
1.4.7 India Insulin Glargine Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Insulin Glargine (2013-2025)
1.5.1 Global Insulin Glargine Sales and Growth Rate (2013-2025)
1.5.2 Global Insulin Glargine Revenue and Growth Rate (2013-2025)

2 Global Insulin Glargine Competition by Players/Suppliers, Type and Application
2.1 Global Insulin Glargine Market Competition by Players/Suppliers
2.1.1 Global Insulin Glargine Sales and Market Share of Key Players/Suppliers (2013-2018)
2.1.2 Global Insulin Glargine Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Insulin Glargine (Volume and Value) by Type
2.2.1 Global Insulin Glargine Sales and Market Share by Type (2013-2018)
2.2.2 Global Insulin Glargine Revenue and Market Share by Type (2013-2018)
2.3 Global Insulin Glargine (Volume and Value) by Region
2.3.1 Global Insulin Glargine Sales and Market Share by Region (2013-2018)
2.3.2 Global Insulin Glargine Revenue and Market Share by Region (2013-2018)
2.4 Global Insulin Glargine (Volume) by Application

3 United States Insulin Glargine (Volume, Value and Sales Price)
3.1 United States Insulin Glargine Sales and Value (2013-2018)
3.1.1 United States Insulin Glargine Sales and Growth Rate (2013-2018)
3.1.2 United States Insulin Glargine Revenue and Growth Rate (2013-2018)
3.1.3 United States Insulin Glargine Sales Price Trend (2013-2018)
3.2 United States Insulin Glargine Sales Volume and Market Share by Players (2013-2018)
3.3 United States Insulin Glargine Sales Volume and Market Share by Type (2013-2018)
3.4 United States Insulin Glargine Sales Volume and Market Share by Application (2013-2018)

4 Europe Insulin Glargine (Volume, Value and Sales Price)
4.1 Europe Insulin Glargine Sales and Value (2013-2018)
4.1.1 Europe Insulin Glargine Sales and Growth Rate (2013-2018)
4.1.2 Europe Insulin Glargine Revenue and Growth Rate (2013-2018)
4.1.3 Europe Insulin Glargine Sales Price Trend (2013-2018)
4.2 Europe Insulin Glargine Sales Volume and Market Share by Players (2013-2018)
4.3 Europe Insulin Glargine Sales Volume and Market Share by Type (2013-2018)
4.4 Europe Insulin Glargine Sales Volume and Market Share by Application (2013-2018)

5 China Insulin Glargine (Volume, Value and Sales Price)
5.1 China Insulin Glargine Sales and Value (2013-2018)
5.1.1 China Insulin Glargine Sales and Growth Rate (2013-2018)
5.1.2 China Insulin Glargine Revenue and Growth Rate (2013-2018)
5.1.3 China Insulin Glargine Sales Price Trend (2013-2018)
5.2 China Insulin Glargine Sales Volume and Market Share by Players (2013-2018)
5.3 China Insulin Glargine Sales Volume and Market Share by Type (2013-2018)
5.4 China Insulin Glargine Sales Volume and Market Share by Application (2013-2018)

6 Japan Insulin Glargine (Volume, Value and Sales Price)
6.1 Japan Insulin Glargine Sales and Value (2013-2018)
6.1.1 Japan Insulin Glargine Sales and Growth Rate (2013-2018)
6.1.2 Japan Insulin Glargine Revenue and Growth Rate (2013-2018)
6.1.3 Japan Insulin Glargine Sales Price Trend (2013-2018)
6.2 Japan Insulin Glargine Sales Volume and Market Share by Players (2013-2018)
6.3 Japan Insulin Glargine Sales Volume and Market Share by Type (2013-2018)
6.4 Japan Insulin Glargine Sales Volume and Market Share by Application (2013-2018)

7 Southeast Asia Insulin Glargine (Volume, Value and Sales Price)
7.1 Southeast Asia Insulin Glargine Sales and Value (2013-2018)
7.1.1 Southeast Asia Insulin Glargine Sales and Growth Rate (2013-2018)
7.1.2 Southeast Asia Insulin Glargine Revenue and Growth Rate (2013-2018)
7.1.3 Southeast Asia Insulin Glargine Sales Price Trend (2013-2018)
7.2 Southeast Asia Insulin Glargine Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia Insulin Glargine Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia Insulin Glargine Sales Volume and Market Share by Application (2013-2018)

8 India Insulin Glargine (Volume, Value and Sales Price)
8.1 India Insulin Glargine Sales and Value (2013-2018)
8.1.1 India Insulin Glargine Sales and Growth Rate (2013-2018)
8.1.2 India Insulin Glargine Revenue and Growth Rate (2013-2018)
8.1.3 India Insulin Glargine Sales Price Trend (2013-2018)
8.2 India Insulin Glargine Sales Volume and Market Share by Players (2013-2018)
8.3 India Insulin Glargine Sales Volume and Market Share by Type (2013-2018)
8.4 India Insulin Glargine Sales Volume and Market Share by Application (2013-2018)

9 Global Insulin Glargine Players/Suppliers Profiles and Sales Data
9.1 Sanofi-Aventis
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Insulin Glargine Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Sanofi-Aventis Insulin Glargine Sales, Revenue, Price and Gross Margin (2013-2018)
9.1.4 Main Business/Business Overview
9.2 Ganlee
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Insulin Glargine Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Ganlee Insulin Glargine Sales, Revenue, Price and Gross Margin (2013-2018)
9.2.4 Main Business/Business Overview
9.3 Biocon
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Insulin Glargine Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Biocon Insulin Glargine Sales, Revenue, Price and Gross Margin (2013-2018)
9.3.4 Main Business/Business Overview

10 Insulin Glargine Maufacturing Cost Analysis
10.1 Insulin Glargine Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Insulin Glargine
10.3 Manufacturing Process Analysis of Insulin Glargine

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Insulin Glargine Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Insulin Glargine Major Manufacturers in 2017
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Insulin Glargine Market Forecast (2018-2025)
14.1 Global Insulin Glargine Sales Volume, Revenue and Price Forecast (2018-2025)
14.1.1 Global Insulin Glargine Sales Volume and Growth Rate Forecast (2018-2025)
14.1.2 Global Insulin Glargine Revenue and Growth Rate Forecast (2018-2025)
14.1.3 Global Insulin Glargine Price and Trend Forecast (2018-2025)
14.2 Global Insulin Glargine Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
14.2.1 Global Insulin Glargine Sales Volume and Growth Rate Forecast by Regions (2018-2025)
14.2.2 Global Insulin Glargine Revenue and Growth Rate Forecast by Regions (2018-2025)
14.2.3 United States Insulin Glargine Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.4 Europe Insulin Glargine Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.5 China Insulin Glargine Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.6 Japan Insulin Glargine Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.7 Southeast Asia Insulin Glargine Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.8 India Insulin Glargine Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Insulin Glargine Sales Volume, Revenue and Price Forecast by Type (2018-2025)
14.3.1 Global Insulin Glargine Sales Forecast by Type (2018-2025)
14.3.2 Global Insulin Glargine Revenue Forecast by Type (2018-2025)
14.3.3 Global Insulin Glargine Price Forecast by Type (2018-2025)
14.4 Global Insulin Glargine Sales Volume Forecast by Application (2018-2025)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Insulin Glargine
Figure Global Insulin Glargine Sales Volume Comparison (M mL) by Type (2013-2025)
Figure Global Insulin Glargine Sales Volume Market Share by Type (Product Category) in 2017
Figure Single Dose Vial Product Picture
Figure Pre-filled Syringe Product Picture
Figure Global Insulin Glargine Sales Comparison (M mL) by Application (2013-2025)
Figure Global Sales Market Share of Insulin Glargine by Application in 2017
Figure Treat type2 diabetes Examples
Table Key Downstream Customer in Treat type2 diabetes
Figure Treat type1 diabetes Examples
Table Key Downstream Customer in Treat type1 diabetes
Figure Global Insulin Glargine Market Size (Million USD) by Regions (2013-2025)
Figure United States Insulin Glargine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Insulin Glargine Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Insulin Glargine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Insulin Glargine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Insulin Glargine Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Insulin Glargine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Insulin Glargine Sales Volume (M mL) and Growth Rate (2013-2025)
Figure Global Insulin Glargine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Market Major Players Insulin Glargine Sales Volume (M mL) (2013-2018)
Table Global Insulin Glargine Sales (M mL) of Key Players/Suppliers (2013-2018)
Table Global Insulin Glargine Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Insulin Glargine Sales Share by Players/Suppliers
Figure 2017 Insulin Glargine Sales Share by Players/Suppliers
Figure Global Insulin Glargine Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Insulin Glargine Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Insulin Glargine Revenue Share by Players/Suppliers (2013-2018)
Table 2017 Global Insulin Glargine Revenue Share by Players
Table 2017 Global Insulin Glargine Revenue Share by Players
Table Global Insulin Glargine Sales (M mL) and Market Share by Type (2013-2018)
Table Global Insulin Glargine Sales Share (M mL) by Type (2013-2018)
Figure Sales Market Share of Insulin Glargine by Type (2013-2018)
Figure Global Insulin Glargine Sales Growth Rate by Type (2013-2018)
Table Global Insulin Glargine Revenue (Million USD) and Market Share by Type (2013-2018)
Table Global Insulin Glargine Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Insulin Glargine by Type (2013-2018)
Figure Global Insulin Glargine Revenue Growth Rate by Type (2013-2018)
Table Global Insulin Glargine Sales Volume (M mL) and Market Share by Region (2013-2018)
Table Global Insulin Glargine Sales Share by Region (2013-2018)
Figure Sales Market Share of Insulin Glargine by Region (2013-2018)
Figure Global Insulin Glargine Sales Growth Rate by Region in 2017
Table Global Insulin Glargine Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Insulin Glargine Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Insulin Glargine by Region (2013-2018)
Figure Global Insulin Glargine Revenue Growth Rate by Region in 2017
Table Global Insulin Glargine Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Insulin Glargine Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Insulin Glargine by Region (2013-2018)
Figure Global Insulin Glargine Revenue Market Share by Region in 2017
Table Global Insulin Glargine Sales Volume (M mL) and Market Share by Application (2013-2018)
Table Global Insulin Glargine Sales Share (%) by Application (2013-2018)
Figure Sales Market Share of Insulin Glargine by Application (2013-2018)
Figure Global Insulin Glargine Sales Market Share by Application (2013-2018)
Figure United States Insulin Glargine Sales (M mL) and Growth Rate (2013-2018)
Figure United States Insulin Glargine Revenue (Million USD) and Growth Rate (2013-2018)
Figure United States Insulin Glargine Sales Price (USD/Ml) Trend (2013-2018)
Table United States Insulin Glargine Sales Volume (M mL) by Players (2013-2018)
Table United States Insulin Glargine Sales Volume Market Share by Players (2013-2018)
Figure United States Insulin Glargine Sales Volume Market Share by Players in 2017
Table United States Insulin Glargine Sales Volume (M mL) by Type (2013-2018)
Table United States Insulin Glargine Sales Volume Market Share by Type (2013-2018)
Figure United States Insulin Glargine Sales Volume Market Share by Type in 2017
Table United States Insulin Glargine Sales Volume (M mL) by Application (2013-2018)
Table United States Insulin Glargine Sales Volume Market Share by Application (2013-2018)
Figure United States Insulin Glargine Sales Volume Market Share by Application in 2017
Figure Europe Insulin Glargine Sales (M mL) and Growth Rate (2013-2018)
Figure Europe Insulin Glargine Revenue (Million USD) and Growth Rate (2013-2018)
Figure Europe Insulin Glargine Sales Price (USD/Ml) Trend (2013-2018)
Table Europe Insulin Glargine Sales Volume (M mL) by Players (2013-2018)
Table Europe Insulin Glargine Sales Volume Market Share by Players (2013-2018)
Figure Europe Insulin Glargine Sales Volume Market Share by Players in 2017
Table Europe Insulin Glargine Sales Volume (M mL) by Type (2013-2018)
Table Europe Insulin Glargine Sales Volume Market Share by Type (2013-2018)
Figure Europe Insulin Glargine Sales Volume Market Share by Type in 2017
Table Europe Insulin Glargine Sales Volume (M mL) by Application (2013-2018)
Table Europe Insulin Glargine Sales Volume Market Share by Application (2013-2018)
Figure Europe Insulin Glargine Sales Volume Market Share by Application in 2017
Figure China Insulin Glargine Sales (M mL) and Growth Rate (2013-2018)
Figure China Insulin Glargine Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Insulin Glargine Sales Price (USD/Ml) Trend (2013-2018)
Table China Insulin Glargine Sales Volume (M mL) by Players (2013-2018)
Table China Insulin Glargine Sales Volume Market Share by Players (2013-2018)
Figure China Insulin Glargine Sales Volume Market Share by Players in 2017
Table China Insulin Glargine Sales Volume (M mL) by Type (2013-2018)
Table China Insulin Glargine Sales Volume Market Share by Type (2013-2018)
Figure China Insulin Glargine Sales Volume Market Share by Type in 2017
Table China Insulin Glargine Sales Volume (M mL) by Application (2013-2018)
Table China Insulin Glargine Sales Volume Market Share by Application (2013-2018)
Figure China Insulin Glargine Sales Volume Market Share by Application in 2017
Figure Japan Insulin Glargine Sales (M mL) and Growth Rate (2013-2018)
Figure Japan Insulin Glargine Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Insulin Glargine Sales Price (USD/Ml) Trend (2013-2018)
Table Japan Insulin Glargine Sales Volume (M mL) by Players (2013-2018)
Table Japan Insulin Glargine Sales Volume Market Share by Players (2013-2018)
Figure Japan Insulin Glargine Sales Volume Market Share by Players in 2017
Table Japan Insulin Glargine Sales Volume (M mL) by Type (2013-2018)
Table Japan Insulin Glargine Sales Volume Market Share by Type (2013-2018)
Figure Japan Insulin Glargine Sales Volume Market Share by Type in 2017
Table Japan Insulin Glargine Sales Volume (M mL) by Application (2013-2018)
Table Japan Insulin Glargine Sales Volume Market Share by Application (2013-2018)
Figure Japan Insulin Glargine Sales Volume Market Share by Application in 2017
Figure Southeast Asia Insulin Glargine Sales (M mL) and Growth Rate (2013-2018)
Figure Southeast Asia Insulin Glargine Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Insulin Glargine Sales Price (USD/Ml) Trend (2013-2018)
Table Southeast Asia Insulin Glargine Sales Volume (M mL) by Players (2013-2018)
Table Southeast Asia Insulin Glargine Sales Volume Market Share by Players (2013-2018)
Figure Southeast Asia Insulin Glargine Sales Volume Market Share by Players in 2017
Table Southeast Asia Insulin Glargine Sales Volume (M mL) by Type (2013-2018)
Table Southeast Asia Insulin Glargine Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Insulin Glargine Sales Volume Market Share by Type in 2017
Table Southeast Asia Insulin Glargine Sales Volume (M mL) by Application (2013-2018)
Table Southeast Asia Insulin Glargine Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Insulin Glargine Sales Volume Market Share by Application in 2017
Figure India Insulin Glargine Sales (M mL) and Growth Rate (2013-2018)
Figure India Insulin Glargine Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Insulin Glargine Sales Price (USD/Ml) Trend (2013-2018)
Table India Insulin Glargine Sales Volume (M mL) by Players (2013-2018)
Table India Insulin Glargine Sales Volume Market Share by Players (2013-2018)
Figure India Insulin Glargine Sales Volume Market Share by Players in 2017
Table India Insulin Glargine Sales Volume (M mL) by Type (2013-2018)
Table India Insulin Glargine Sales Volume Market Share by Type (2013-2018)
Figure India Insulin Glargine Sales Volume Market Share by Type in 2017
Table India Insulin Glargine Sales Volume (M mL) by Application (2013-2018)
Table India Insulin Glargine Sales Volume Market Share by Application (2013-2018)
Figure India Insulin Glargine Sales Volume Market Share by Application in 2017
Table Sanofi-Aventis Basic Information List
Table Sanofi-Aventis Insulin Glargine Sales (M mL), Revenue (Million USD), Price (USD/Ml) and Gross Margin (2013-2018)
Figure Sanofi-Aventis Insulin Glargine Sales Growth Rate (2013-2018)
Figure Sanofi-Aventis Insulin Glargine Sales Global Market Share (2013-2018)
Figure Sanofi-Aventis Insulin Glargine Revenue Global Market Share (2013-2018)
Table Ganlee Basic Information List
Table Ganlee Insulin Glargine Sales (M mL), Revenue (Million USD), Price (USD/Ml) and Gross Margin (2013-2018)
Figure Ganlee Insulin Glargine Sales Growth Rate (2013-2018)
Figure Ganlee Insulin Glargine Sales Global Market Share (2013-2018)
Figure Ganlee Insulin Glargine Revenue Global Market Share (2013-2018)
Table Biocon Basic Information List
Table Biocon Insulin Glargine Sales (M mL), Revenue (Million USD), Price (USD/Ml) and Gross Margin (2013-2018)
Figure Biocon Insulin Glargine Sales Growth Rate (2013-2018)
Figure Biocon Insulin Glargine Sales Global Market Share (2013-2018
Figure Biocon Insulin Glargine Revenue Global Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Insulin Glargine
Figure Manufacturing Process Analysis of Insulin Glargine
Figure Insulin Glargine Industrial Chain Analysis
Table Raw Materials Sources of Insulin Glargine Major Players in 2017
Table Major Buyers of Insulin Glargine
Table Distributors/Traders List
Figure Global Insulin Glargine Sales Volume (M mL) and Growth Rate Forecast (2018-2025)
Figure Global Insulin Glargine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Insulin Glargine Price (USD/Ml) and Trend Forecast (2018-2025)
Table Global Insulin Glargine Sales Volume (M mL) Forecast by Regions (2018-2025)
Figure Global Insulin Glargine Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global Insulin Glargine Sales Volume Market Share Forecast by Regions in 2025
Table Global Insulin Glargine Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global Insulin Glargine Revenue Market Share Forecast by Regions (2018-2025)
Figure Global Insulin Glargine Revenue Market Share Forecast by Regions in 2025
Figure United States Insulin Glargine Sales Volume (M mL) and Growth Rate Forecast (2018-2025)
Figure United States Insulin Glargine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Europe Insulin Glargine Sales Volume (M mL) and Growth Rate Forecast (2018-2025)
Figure Europe Insulin Glargine Revenue and Growth Rate Forecast (2018-2025)
Figure China Insulin Glargine Sales Volume (M mL) and Growth Rate Forecast (2018-2025)
Figure China Insulin Glargine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Insulin Glargine Sales Volume (M mL) and Growth Rate Forecast (2018-2025)
Figure Japan Insulin Glargine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Insulin Glargine Sales Volume (M mL) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Insulin Glargine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Insulin Glargine Sales Volume (M mL) and Growth Rate Forecast (2018-2025)
Figure India Insulin Glargine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Global Insulin Glargine Sales (M mL) Forecast by Type (2018-2025)
Figure Global Insulin Glargine Sales Volume Market Share Forecast by Type (2018-2025)
Table Global Insulin Glargine Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Insulin Glargine Revenue Market Share Forecast by Type (2018-2025)
Table Global Insulin Glargine Price (USD/Ml) Forecast by Type (2018-2025)
Table Global Insulin Glargine Sales (M mL) Forecast by Application (2018-2025)
Figure Global Insulin Glargine Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources



• 英文レポート名:Global Insulin Glargine Sales Market Report 2018
• 日本語訳:インスリングラルギンの世界市場2018
• レポートコード:D101268お問い合わせ(見積依頼・ご注文・質問)